Journal of Biochemistry and Biotechnology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Opinion Article - Journal of Biochemistry and Biotechnology (2024) Volume 7, Issue 6

AI-Enabled Protein Folding Predictions: Applications in Biotech

Emily Liu*

Bioethics Department, University of Hong Kong, Hong Kong

*Corresponding Author:
Emily Liu
Bioethics Department
University of Hong Kong, Hong Kong
E-mail: emily.liu@email.com

Received: 04-Dec-2024, Manuscript No. AABB-24-153761; Editor assigned: 05-Dec-2024, Pre QC No. AABB-24-153761 (PQ); Reviewed: 12-Dec-2024, QC No. AABB-24-153761; Revised: 19-Dec-2024, Manuscript No. AABB-24-153761 (R); Published: 26-Dec-2024, DOI:10.35841/aabb-7.6.237

Citation: Liu E. AI-Enabled Protein Folding Predictions: Applications in Biotech. J Biochem Biotech 2024; 7(6):237.

Visit for more related articles at Journal of Biochemistry and Biotechnology

Introduction

Proteins are essential molecules that perform a wide range of functions within biological systems. The shape or "fold" of a protein determines its function, making accurate protein folding predictions crucial for understanding cellular processes, drug design, and disease mechanisms. However, predicting how a protein will fold base solely on its amino acid sequence has been a long-standing challenge in molecular biology. Recent advancements in artificial intelligence (AI) have transformed this field, particularly with the development of tools like AlphaFold by DeepMind. This article explores how AI-enabled protein folding predictions are revolutionizing biotechnology and their potential applications in medicine, drug discovery, and synthetic biology [1].

Protein folding is a complex process where a linear chain of amino acids folds into a three-dimensional structure, which determines the protein's function. Misfolding of proteins can lead to diseases such as Alzheimer’s, Parkinson’s, and cystic fibrosis. Predicting a protein’s final structure is incredibly challenging because of the vast number of possible conformations a protein can take. Traditional methods of determining protein structures, such as X-ray crystallography and nuclear magnetic resonance (NMR), are time-consuming and expensive. AI has now become a powerful tool to predict protein structures rapidly and accurately, overcoming these limitations [2].

AlphaFold, an AI system developed by DeepMind, has been a game-changer in the field of protein folding. In 2020, AlphaFold achieved unprecedented accuracy in the Critical Assessment of Protein Structure Prediction (CASP) competition, where it successfully predicted the 3D structures of proteins with a high degree of accuracy. AlphaFold uses deep learning techniques to analyze protein sequences and predict their folding patterns. The system relies on a vast amount of data, including known protein structures, to learn the relationships between amino acid sequences and their final shapes. This breakthrough has opened up new possibilities for biotech, accelerating research and innovation [3].

One of the most promising applications of AI-enabled protein folding predictions is in drug discovery. Many diseases are caused by malfunctioning proteins, and drugs often work by interacting with these proteins to restore normal function. Accurately predicting protein structures allows scientists to understand how proteins interact with potential drugs, speeding up the process of identifying promising drug candidates. AlphaFold and similar AI tools enable researchers to target proteins that were previously too difficult to study, opening new avenues for therapeutic interventions. This is particularly important in diseases like cancer, where specific proteins play critical roles in disease progression [4].

During the COVID-19 pandemic, AI-enabled protein folding tools played a crucial role in accelerating research. Understanding the structure of the SARS-CoV-2 virus’s spike protein, which allows the virus to enter human cells, was vital for developing vaccines and treatments. AI tools like AlphaFold quickly predicted the structure of the spike protein, providing insights into how the virus infects cells and how to block this process. This helped researchers design vaccines and antiviral drugs in record time. The success of AI in COVID-19 research demonstrates its potential in responding to future pandemics and emerging infectious diseases [5].

AI-enabled protein folding predictions are also transforming protein engineering and synthetic biology. In synthetic biology, researchers design and create new proteins with specific functions, such as enzymes that can break down plastic or proteins that can be used in biofuels. Accurate protein folding predictions are essential for designing these proteins, as their function depends on their structure. AI tools allow researchers to predict the folding of newly designed proteins, ensuring that they will behave as expected. This has significant implications for industries like biotechnology, energy, and environmental science, where custom proteins can solve real-world problems [6].

Personalized medicine involves tailoring treatments to individual patients based on their genetic makeup and unique biological characteristics. Protein folding predictions are critical in personalized medicine because many genetic diseases are caused by mutations that lead to protein misfolding. AI can help predict how these mutations affect protein structure and function, allowing for more targeted and effective treatments. For example, in the case of cystic fibrosis, AI tools can predict how different mutations in the CFTR protein affect its folding and function, guiding the development of personalized therapies that restore the protein’s normal function [7].

Proteins rarely function in isolation; they often interact with other proteins to perform complex tasks within the cell. Understanding protein-protein interactions is crucial for understanding many biological processes and diseases. AI-enabled protein folding predictions can provide insights into how proteins interact with each other, offering new ways to target these interactions in drug discovery. For example, many cancer therapies are designed to disrupt interactions between proteins that drive tumor growth. AI can help identify these critical interactions and predict how disrupting them will affect cellular function, leading to more effective cancer treatments [8].

While AI-enabled protein folding predictions offer immense potential, they also raise ethical considerations. One concern is the accessibility of these powerful AI tools. Currently, technologies like AlphaFold are available to a limited number of researchers, raising concerns about unequal access to cutting-edge scientific resources. Additionally, the use of AI in drug discovery and protein engineering could lead to ethical dilemmas, such as the creation of synthetic organisms or the use of AI-designed proteins in controversial applications. Ensuring that AI in biotech is used responsibly and ethically will be crucial as the technology continues to advance [9].

The future of AI-enabled protein folding predictions holds great promise. Continued advancements in deep learning and AI models will likely lead to even more accurate and efficient predictions, further transforming fields like drug discovery, synthetic biology, and personalized medicine. Integrating AI tools with experimental techniques, such as cryo-electron microscopy (cryo-EM) and mass spectrometry, could provide even deeper insights into protein structures and functions. As AI continues to improve, it could enable the prediction of dynamic protein behaviors, such as folding pathways and conformational changes, providing a more comprehensive understanding of proteins in action [10].

Conclusion

AI-enabled protein folding predictions are revolutionizing the field of biotechnology. By providing rapid and accurate insights into protein structures, AI tools like AlphaFold are accelerating drug discovery, improving personalized medicine, and enabling advances in synthetic biology. The applications of this technology are vast, from designing new proteins for industrial purposes to developing targeted therapies for genetic diseases. However, as with any powerful technology, it is essential to consider the ethical implications and ensure that AI in biotech is used for the benefit of all. The future of protein folding predictions, powered by AI, promises to unlock new frontiers in science and medicine.

References

  1. Jumper J, Evans R, Pritzel A, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583-9.

    2. Indexed at, Google Scholar, Cross Ref

  2. Senior AW, Evans R, Jumper J, et al. Improved protein structure prediction using potentials from deep learning. Nature.2020;577(7792):706-10.

    3. Indexed at, Google Scholar, Cross Ref

  3. Yang J, Yan R, Roy A. The I-TASSER Suite: protein structure and function prediction. Nature. 2015;12(1):7-8.

    4. Indexed at, Google Scholar, Cross Ref

  4. Baek M, DiMaio F, Anishchenko I, et al. Accurate prediction of protein structures and interactions using a three-track neural network. Science. 2021;373(6557):871-6.

    5. Indexed at, Google Scholar, Cross Ref

  5. Finkelstein AV, Ptitsyn O. Protein physics: a course of lectures. Elsevier. 2016.

    6. Indexed at, Google Scholar

  6. Chen L, Li Q, Nasif KF, et al. AI-driven deep learning techniques in protein structure prediction. Int J Mol Sci. 2024;25(15):8426.

    7. Indexed at, Google Scholar, Cross Ref

  7. Komaroff AL. Breakthrough discovery in protein structure prediction and the promise of new treatments. JAMA. 2021;326(14):1369-70.

    8. Indexed at, Google Scholar, Cross Ref

  8. Bryngelson JD, Onuchic JN, Socci ND. Funnels, pathways, and the energy landscape of protein folding: a synthesis.       Proteins Struct Funct Bioinf. 1995;21(3):167-95.

    9. Google Scholar

  9. Blanco-Gonzalez A, Cabezon A, Seco-Gonzalez A, et al. The role of AI in drug discovery: challenges, opportunities, and strategies. Pharmaceuticals. 2023;16(6):891.

    10. Google Scholar

  10. Kuhlman B, Bradley P. Advances in protein structure prediction and design. Nat Rev Mol Cell Biol. 2019;20(11):681-97.

    11. Google Scholar

Get the App